The research team used electronic health records data to divide patients into four groups to track symptoms across different obesity levels.
Researchers summarize key insights from the world’s first comprehensive investigation into how a pandemic started.
Objectives The mental health impacts of COVID-19 on frontline healthcare workers have been reported globally; however, there is limited evidence from low-income countries such as Ethiopia. We reviewed ...
Billions more pumped into service with little to show for life expectancy levels and waiting lists, say critics ...
Analysts say cost has always been a factor, but larger forces are at play, including demographics. Michigan's population is ...
Opinion
Great Barrington Declaration author Jay Bhattacharya takes control of CDC as measles cases surge
The Trump administration has placed a Stanford economist who championed mass infection policies during COVID-19 as the single official in charge of both the NIH and CDC.
Cyprus Mail on MSN
Building Europe’s frontline against future pandemics
From routine infections to emerging health threats, being prepared matters. Dr Lennie Derde, newly appointed CEO of the Ecraid medical research network, explains how European collaboration and EU ...
Morning Overview on MSN
Universal nasal spray vaccine could block COVID, flu, and pneumonia
Stanford Medicine researchers have developed an experimental nasal spray vaccine that protected mice against SARS‑CoV‑2, influenza, and Streptococcus pneumoniae (a cause of bacterial pneumonia) with a ...
During the postwar decades, American medical science reached a sort of financial equilibrium: The government would fund basic ...
UK Research and Innovation has published its first AI Strategy, setting out a long-term plan backed by £1.6 billion to strengthen the UK’s AI research, skills and infrastructure. The framework ...
NOAA is opening up collaboration with public comment for exempted fishing permits.
Morning Overview on MSN
New nasal vaccine shields lungs for months from viruses, bacteria, and allergens
Stanford Medicine researchers have developed an experimental nasal vaccine that shielded mouse lungs for at least three months against a striking range of respiratory threats, from SARS-CoV-2 and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results